Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
8,257.66
7,448.25
8,985.81
8,409.53
8,135.60
7,155.22
8,861.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,257.66
7,448.25
8,985.81
8,409.53
8,135.60
7,155.22
8,861.62
Raw Material Cost
3,184.62
3,694.82
3,727.00
3,641.93
3,397.54
3,493.61
3,734.73
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.07
7.27
6.45
5.31
4.99
5.22
5.07
Selling and Distribution Expenses
1,593.04
1,777.91
1,535.59
1,431.05
1,446.72
2,030.34
900.65
Other Expenses
79.57
99.62
68.14
69.87
62.55
94.34
68.71
Total Expenditure (Excl Depreciation)
5,579.39
6,476.18
5,950.48
5,776.98
5,474.73
6,472.54
5,327.50
Operating Profit (PBDIT) excl Other Income
2678.2999999999997
972.0999999999999
3035.2999999999997
2632.6
2660.8999999999996
682.6999999999999
3534.1000000000004
Other Income
-119.84
26.41
41.26
297.41
438.41
366.89
49.39
Operating Profit (PBDIT)
2,537.61
1,220.94
3,423.82
3,295.24
3,487.31
1,389.13
3,929.99
Interest
6.07
7.27
6.45
5.31
4.99
5.22
5.07
Exceptional Items
1.01
-0.18
0.42
0.25
0.00
-0.86
0.60
Gross Profit (PBDT)
5,073.05
3,753.43
5,258.81
4,767.60
4,738.06
3,661.62
5,126.88
Depreciation
0.00
441.75
441.75
430.93
430.93
416.37
416.37
Profit Before Tax
2,532.55
771.74
2,976.04
2,859.25
3,051.40
966.69
3,509.15
Tax
114.81
134.78
403.50
322.54
361.67
-68.21
382.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,329.66
565.73
2,501.28
2,440.19
2,628.58
1,031.41
3,076.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,329.66
565.73
2,501.28
2,440.19
2,628.58
1,031.41
3,076.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
96.88
71.85
79.92
99.95
63.97
5.90
50.37
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,426.54
637.58
2,581.20
2,540.14
2,692.55
1,037.32
3,126.71
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
40,110.09
38,093.33
39,297.61
39,040.65
38,590.00
35,856.36
37,093.90
Earnings per share (EPS)
1.92
0.47
2.06
2.01
2.17
0.86
2.53
Diluted Earnings per share
1.92
0.47
2.06
2.01
2.17
0.86
2.53
Operating Profit Margin (Excl OI)
32.18%
10.11%
32.73%
30.52%
32.18%
8.47%
39.09%
Gross Profit Margin
30.67%
16.29%
38.04%
39.12%
42.8%
19.33%
44.3%
PAT Margin
28.21%
7.6%
27.84%
29.02%
32.31%
14.41%
34.72%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 1.50% vs -12.26% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -9.88% vs -14.84% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -12.84% vs -10.35% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 22.00% vs 11.11% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
8,257.66
0
8,257.66
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,257.66
0
8,257.66
Raw Material Cost
3,184.62
0
3,184.62
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.07
0
6.07
Selling and Distribution Expenses
1,593.04
0
1,593.04
Other Expenses
79.57
0.00
79.57
Total Expenditure (Excl Depreciation)
5,579.39
0
5,579.39
Operating Profit (PBDIT) excl Other Income
2,678.27
0.00
2,678.27
Other Income
-119.84
0
-119.84
Operating Profit (PBDIT)
2,537.61
0
2,537.61
Interest
6.07
0
6.07
Exceptional Items
1.01
0
1.01
Gross Profit (PBDT)
5,073.05
0
5,073.05
Depreciation
0.00
0
0.00
Profit Before Tax
2,532.55
0
2,532.55
Tax
114.81
0
114.81
Provisions and contingencies
0
0
0.00
Profit After Tax
2,329.66
0
2,329.66
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,329.66
0
2,329.66
Share in Profit of Associates
0
0
0.00
Minority Interest
96.88
0
96.88
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,426.54
0
2,426.54
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
40,110.09
0
40,110.09
Earnings per share (EPS)
1.92
0
1.92
Diluted Earnings per share
1.92
0
1.92
Operating Profit Margin (Excl OI)
32.18%
0%
0.00
32.18%
Gross Profit Margin
30.67%
0%
0.00
30.67%
PAT Margin
28.21%
0%
0.00
28.21%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 825.77 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 10.87% vs -17.11% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 1.50% vs -12.26% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 242.65 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 280.57% vs -75.30% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -9.88% vs -14.84% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 265.75 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 122.48% vs -64.69% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -12.84% vs -10.35% in Mar 2025
Quarterly - Interest
Interest 0.61 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -16.44% vs 12.31% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 22.00% vs 11.11% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.18%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
